|Articles|January 8, 2019

Turnover Within CRO Companies Remains Persistently High

CRO companies are battling high turnover levels, but a new report from BDO USA, LLP, finds that compensation strategies generally have not made enough adjustments to their compensation strategy to address this on going issue. This report examines compensation and benefits trends in the CRO industry over the last 10 years, with a special focus on clinical research associates.

Read the full release here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Trending on Applied Clinical Trials Online

Turnover Within CRO Companies Remains Persistently High

Related Content

Why Payment Performance Has Become a Competitive Differentiator for Sponsors

Speed, Discipline, and the New Rules of Biotech Development: Q&A with Stella K. Vnook, PhD, Kaida BioPharma and Aviva Ventures

ACT Brief: AI Literacy and Ecosystem Adoption Requirements, CRO Operating Models Under Agentic AI Pressure, and Platform Collaborations in Vaccine and Antibody Discovery

When the Slack Runs Out: AI and the CRO Operating Model

What Needs to Be True Across Sponsors, Sites, and Regulators for Operation TrialBlazer to Succeed

Trending on Applied Clinical Trials Online

Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations

When the Slack Runs Out: AI and the CRO Operating Model

ACT Brief: Trial Failures as Administrative Problems, CRO Consolidation for Global Trial Reach, and FDA Approval of First FOP Treatment

What Needs to Be True Across Sponsors, Sites, and Regulators for Operation TrialBlazer to Succeed

Speed, Discipline, and the New Rules of Biotech Development: Q&A with Stella K. Vnook, PhD, Kaida BioPharma and Aviva Ventures